Community-Originated Research to Identify Access Gaps in Over-the-Counter Naloxone Availability in Connecticut Pharmacies
Abstract Background Naloxone, a life-saving medication that reverses opioid overdoses, was available in the United States only by prescription until March 2023, when the federal government approved nasal-spray formulations for over the counter sales to expand access. We assessed the availability of...
Saved in:
| Main Authors: | Katherine Hill, Peter Canning, Zoey Canning, Cameron Breen, Liz Evans, Mark Jenkins, Mark Nickel, Ken Plourd, Robert Heimer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Harm Reduction Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12954-025-01268-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transforming Opioid Overdose Prevention in the United States: Leveraging FDA’s Narcan Approval to Foster a Culture of Health
by: Rangachari P, et al.
Published: (2025-06-01) -
Understanding the Impact of Naloxone Distribution in Undeserved Communities
by: Chadwick Huss, et al.
Published: (2024-11-01) -
Implementation of an EMS‐based naloxone distribution program: A qualitative evaluation
by: Emily E. Ager, et al.
Published: (2024-10-01) -
Reported outcomes from a community naloxone training and distribution program
by: Kevin Frederiks, et al.
Published: (2025-06-01) -
Examining naloxone access and interest in secondary naloxone distribution on an American Indian Reservation in the Northern Midwest of the United States
by: Kristin E. Schneider, et al.
Published: (2024-12-01)